Soybean bioactive components and their implications to health - A review

Food Reviews International

Volumn 24, Issue 2, 2008, Pages 252-276

  Isanga, Joel ^a,b   Zhang, Guo Nong ^a  

^a JIANGNAN UNIVERSITY   (China)

^b Faculty of Science   (Uganda)

Author keywords

Bioactive components; Health; Phytochemicals; Soybean

Indexed keywords

BIOACTIVE COMPONENTS; BIOACTIVE COMPOUNDS; CANCER PREVENTION; CARDIO-VASCULAR DISEASE; CHOLESTEROL REDUCTION; DISEASE PREVENTION; PHYTOCHEMICALS; SOYBEAN;

DISEASES; FLAVONOIDS;

HEALTH;

GLYCINE MAX;

EID: 41249093278     PISSN: 87559129     EISSN: 15256103     Source Type: Journal    
DOI: 10.1080/87559120801926351     Document Type: Article

References (212)

1. Gibbs, B.F.; Zougman, A.; Masse, R.; Mulligan, C. Production and characterization of bioactive peptides from soy hydrolysate and soy-fermented food. Food Res. Int. 2004, 37 (2): 123-131.
2. Messina, M.J.; Persky, V.; Setchell, D.R.; Barnes, S. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr. Cancer 1994, 21: 113-131.
3. Messina, M.; Barnes, S. The role of soy products in reducing risk of cancer. J.Natl. Cancer Inst. 1991, 83: 541-546.
4. Wu, A.H.; Ziegler, R.G.; Nomura, A.M.Y.; West, D.W.; Kolonel, L.N.; Horn-Ross, P.L.; Hoover, R.N.; Pike, M.C. Soy intake and risk of breast cancer in Asians and Asian Americans. Am. J. Clin. Nutr. 1998, 68: 1437S-1443S.
5. Arjmandi, B.H.; Getlinger, M.J.; Goyal, N.V.; Alekel, L.; Hasler, C.M.; Juma, S.; Drum, M.L.; Hollis, B.W.; Kukreja, S.C. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am. J. Clin. Nutr. 1998, 68: 1358S-1363S.
6. Barnes, S.; Kirk, M.; Coward, L. Isoflavones and their conjugates in soy foods: Extraction conditions and analysis by HPLC-Mass spectrometry. J. Agric. Food Chem. 1994, 42: 2466-2474.
7. Fico, G.; Braca, A.; Bilia, A.R.; Tome, F.; Morelli, I. Flavonol glycosides from the flowers of Aconitum paniculatum. J. Nat. Prod. 2000, 63: 1563-1565.
8. Ranich, T.; Bhathena, S.J.; Velasquez, M.T. Protective effects of dietary phytoestrogens in chronic renal disease. J. Renal Nutri. 2001, 11: 183-193.
9. Franke, A.A.; Custer, L.J.; Cerna, C.M.; Narala, K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc. Soc. Exp. Biol. Med. 1995, 208: 18-26.
10. Ho, S.C.; Woo, J.L.F.; Leung, S.S.F.; Sham, A.L.K.; Lam, T.H.; Janus, E.D. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J. Nutr. 2000, 130: 2590-2593.
11. Hillis, W.E.; Isoi, K. Variation in the chemical composition of Eucalyptus Sideroxylon. Phytochemistry 1965, 4: 541-550.
12. Huff, M.W.; Roberts, D.C.K.; Carroll, K.K. Long-term effects of semipurified diets containing casein or soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits. Atherosclerosis 1982, 41: 336-372.
13. Lucas, E.A.; Khalil, D.A.; Daggy, B.P.; Arjmandi, B.H. Ethanol-extracted soy protein isolate does not modulate serum cholesterol in golden Syrian hamsters: A model of postmenopausal hypercholesterolemia. J. Nutri. 2001, 131: 211-214.
14. Food and Drug Administration (FDA). Food and Drug Administration, Food labeling, health claims, soy proteins, and coronary heart disease. Fed. Reg. 1999, 57: 699-733.
15. Weisburger, J.H. Eat to live, not live to eat. Nutrition 2000, 16 (9): 767-773.
16. Caragay, A.B. Cancer-preventive foods and ingredients. Food Tech. 1992, 46: 65-68.
17. Answers. Com. Dictionary definition of phytochemical. The American Heritage® Dictionary of the English Language. Houghton Mifflin Company; 2004. http://www.answers.com. Accessed 27 January 2007.
18. Ikeda, I.; Sugano, M. Some aspects of mechanism of inhibition of cholesterol absorption by β-sitosterol. Biochimica et Biophysica Acta 1983, 732: 651-658.
19. Rao, A.V.; Gurfinkel, DM. Dietary saponins and human health. In: Olezek, W.; Marston, A., editors. Saponins in food, feedstuffs and medicinal plants: Proceedings of the phytochemical society of Europe. The Netherlands: Kluwer Academic Publishers, 2000; 255-270.
20. Knight, D.C.; Eden, J.A. A review of the clinical effects of phytoestrogens. Obsted. Gynecol. 1996, 87: 897-904.
21. Davis, S.R.; Dalais, F.S.; Simpson, E.R.; Murkies, A.L. Phytoestrogens in health and disease. Recent Prog. Horm. Res. 1999, 54: 185-210.
22. Clarke, D.B.; Lloyd, A.S. Dietary exposure estimates of isoflavones from the 1998 UK total diet study. Food Addit. Contam. 2004, 21: 305-316.
23. Liu, Z.; Li, W.; Sun, J.; Liu, C.; Zeng, Q.; Huang, J. Intake of soy foods and soy isoflavones by rural adult women in China. Asia Pac. J. Clin. Nutr. 2004, 13: 204-209.
24. Anthony, M.S.; Clarkson, T.B.; Hughes, C.L.; Morgan, T.M.; Burke, G.L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Clin. Nutr. 1996, 126: 43-50.
25. Alekel, L.; Hasler, C.M.; Juma, S.; Drum, B.W.; Kukreja, S.C. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am. J. Clin. Nutr. 1998, 68: 1358S-1363S.
26. Kris-Etherton, P.M.; Hecker, K.D.; Bonanome, A.; Coval, S.M.; Binkoski, A.E.; Hilpert, K.F. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113: 71S-88S.
27. Lusas, E.W.; Riaz, M.N. Soy protein products: processing and use. J. Nutr. 1995, 125: 573S-580S.
28. Anderson, J.; Gamer, S. Phytoestrogens and human function. Nutrition Today 1997, 32: 232-239.
29. Sirtori, C.R. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Safety 2001, 24: 665-682.
30. Cassidy, A.; Bingham, S.; Setchell, K. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr. 1994, 60: 333-340.
31. Wang, H.J.; Murphy, P.A. Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 1994, 42: 1666-1673.
32. Kao, T.H.; Chen, B.H. An improved method for determination of isoflavones in soybean powder by liquid chromatography. Chromatographia 2002, 56: 423-430.
33. Murphy, P.A.; Barua, K.; Hauck, C.C. Solvent extraction selection in the determination of isoflavones in soy foods. J. Chromatography B 2002, 777: 129-138.
34. Birt, D.F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacol. Therapeutics 2001, 90: 157-177.
35. Barnes, S.; Coward, L.; Kirk, M.; Sfakianos, J. HPLC-mass spectrometry analysis of isoflavones. Proc. Soc. Exp. Bio. Med. 1998, 217: 254-262.
36. Ho, H.M.; Chen, R.Y.; Leung, L.K.; Chan, F.L.; Huang, Y.; Chen, Z.Y. Difference in flavonoid and isoflavone profile between soybean and soy leaf. Biomedicine and Pharmacotherapy 2002, 56: 289-295.
37. Piskula, M.K.; Yamakoshi, J.; Iwai, Y. Daidzein and genistein but their glucosides are absorbed from the rat stomach. FEBS Lett. 1999, 447: 287-291.
38. Setchell, K.D.R. Non-steroidal estrogens of dietary origin: possible roles in health and disease, metabolism and physiological effects. Proc. Nutr. Soc. NZ 1995, 20: 1-21.
39. Setchell, K.D.R.; Adlercreutz, H. Mammalian lignans and phyto-oestrogens: recent studies on their formation, metabolism and biological role in health and disease. In: The role of gut microflora in toxicity and cancer, Rowland, I, Ed.; Academic Press: New York,; 1988; 315-345.
40. Axelson, M.; Kirk, D.N.; Cooley, G.; Farrant, R.D.; Lawson, A.M.; Setchell, K.D.R. The identification of the weak oestrogen equol (7-hydroxy-3-(4′-hydroxyphenyl chroman) in human urine. Biochem. J. 1982, 201, 353-357.
41. Joannou, G.E.; Kelly, G.E.; Reeder, A.Y.; Waring, M.A.; Nelson, C. A urinary profile study of dietary phytoestrogens: the identification and mode of metabolism of new isoflavonoids. J. Steroid Biochem. Molec. Biol. 1995, 54, 167-184.
42. Bennetts, H.W.; Underwood, E.J.; Shier, F.L. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust. Vet. J. 1946, 22, 2-12.
43. Setchell, K.D.; Gosselin, S.J.; Welsh, M.B.; Johnston, J.O.; Balistreri, W.F.; Kramer, L.W.; Dresser, B.L.; Tarr, M.J. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 1987, 93 (2), 225-233.
44. Ricciotti, H.A.; Khaodhiar, L.; Blackburn, G.L. Daidzein-rich isoflavone-aglycones for menopausal symptoms. Int. J. Gynecol. Obst. 2005, 89 (1), 65-66.
45. Jin, Z.; Macdonald, R.S. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J. Nutr. 2002, 132 (10), 3186-3190.
46. Arjmandi, B.H.; Lucas, E.A.; Khalil, D.A.; Devareddy, L.; Smith, B.J.; Mcdonald, J.; Arquitt, A.B.; Payton, M.E.; Mason, C. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr. J. 2005, 4: 8.
47. Morabito, N.; Crisafulli, A.; Vergara, C. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J. Bone Miner. Res. 2002, 17, 1904-1912.
48. Fanti, O.; Faugere, M.C.; Gang, Z. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism. Am. J. Clin. Nutr. 1998, 68: S1517-S1518.
49. Brandi, M.L. Natural and synthetic isoflavones in the prevention and treatment of chronic diseases. Calcif Tissue Int. 1997, 61: S5-S8.
50. Picherit, C.; Coxam, V.; Bennetau-Pelissero, C.; Kati-Coulibaly, S.; Davicco, M.J.; Lebecque, P. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J. Nutr. 2000, 130: 1675-1681.
51. Fernandes, G.; Lawrence, R.; Sun, D. Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot. Essent. Fatty Acids 2003, 68: 361-372.
52. Blum, S.C.; Heaton, S.N.; Bowman, B.M.; Hegsted, M.; Miller, S.C. Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats. J. Nutr. 2003, 133: 1244-1249.
53. Picherit, C.; Bennetau-Pelissero, C.; Chanteranne, B.; Lebecque, P.; Davicco, M.J.; Barlet, J.P. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J. Nutr. 2001, 131: 723-728.
54. Blair, H.C.; Jordan, S.E.; Peterson, T.G.; Barnes, S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J. Cell Biochem. 1996, 61: 629-637.
55. Yamaguchi, M.; Gao, Y.H. Anabolic effect of genistein on bone metabolism in the femoral-metaphyseal tissues of elderly rats is inhibited by the anti-estrogen tamoxifen. Res. Exp. Med. (Berl.) 1997, 197: 101-107.
56. Alekel, D.L.; Germain, A.S.; Peterson, C.T.; Hanson, K.B.; Stewart, J.W.; Toda, T. Isoflavonerich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 2000, 72: 844-852.
57. Horiuchi, T.; Onouchi, T.; Takahashi, M.; Ito, H.; Orimo, H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int. 2000, 11: 721-724.
58. Arjmandi, B.H.; Khalil, DA.; Smith, B.J.; Lucas, E.A.; Juma, S.; Payton, M.E. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J. Clin. Endocrinol. Metab. 2003, 88: 1048-1054.
59. Kreijkamp, K.S.; Kok, L.G, D.E.; De Haan, E.H.; Aleman, A.; Lampe, J.W. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004, 292: 65-74.
60. Fanti, P.; Monier-Faugere, M.C.; Geng, Z. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos. Int. 1998, 8, 274-281.
61. Watkins, B.A.; Reinwald, S.; Li, Y.; Seifert, M.F. Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats. J. Nutri. Biochem. 2005, 16(8) : 479-488.
62. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyro sine-specific protein kinases. J. Biol. Chem. 1987, 262: 5592-5595.
63. Barnes, S.; Peterson, G. Biochemical targets of the isoflavone genistein in tumor cell lines. PSEBM 1995, 208: 103-108.
64. Mitchell, J.H.; Collins, A.R. Effect of a soy milk supplement on plasma cholesterol levels and oxidative DNA damage in men - a pilot study. Eu.r J. Nutr. 1999, 38: 143-148.
65. Record, LR.; Dreosti, I.E.; Mcinerney, J. The antioxidant activity of genistein in vitro. J. Nutr. Biochem. 1995, 6: 481-485.
66. Cai, Q.; Wei, H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr. Cancer 1996, 25(1): 1-7.
67. Sarkar, F.H.; Li, Y. Soy isoflavones and cancer prevention. Cancer Invest. 2003, 21: 744-757.
68. Adlercreutz, H.; Markkanen, H.; Watanabe, S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993, 342: 1209-1210.
69. Mills, P.; Beeson, W.; Philips, R.; Fraser, G. Cohort study of diet, lifestyle and prostate cancer in Adventist men. Cancer Causes & Control 1998, 64: 598-604.
70. Messina, M. Isoflavone intakes by Japanese were overestimated. Am. J. Clin. Nutr. 1995, 62: 645-649.
71. Kimira, M.; Arai, Y.; Shimoi, K.; Watanabe, S. Japanese intake of flavonoids and isoflavonoids from foods. J. Epidemiol. 1998, 8: 168-175.
72. Chen, Z.; Zheng, W.; Custer, L.J.; Dai, Q.; Shu, X.O.; Jin, F.; Franke, A.A. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr. Cancer 1999, 33: 82-87.
73. Arai, Y.; Uehara, M.; Sato, Y.; Kimira, M.; Eboshida, A.; Adlercreutz, H.; Watanabe, S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol. 2000, 10: 127-135.
74. Jacobsen, B.K.; Knutsen, S.F.; Fraser, G.E. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (US). Cancer Causes & Control 1998, 9: 553-557.
75. Okura, A.; Arakawa, H.; Oka, H.; Yoshinari, T.; Monden, Y. Effect of genistein on topoisomerase activity and on the growth of [val 12] Ha-ras transformed NIH 3T3 cells. Biochem. Biophys. Res. Comm. 1998, 157: 183-189.
76. Fotsis, T.; Pepper, M.; Adlercreutz, H.; Fleischmann, G.; Hase, T.; Montesano, R.; Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. 1993, 90: 2690-2694.
77. Zava, D.; Duwe, G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 1997, 27(1): 31-40.
78. Constantinou, A.I.; Mehta, R.G.; Vaughan, A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res. 1996, 16: 3293-3298.
79. Guo, H.; Han, Z.; Wang, G.J. Effect of daidzein supplemented in diet on the growth performance and related endocrine function in male rats. J. Nanjing Agric. Univ. 2001, 24: 59-61.
80. Hutchison, G.B. Epidemiology of prostatic cancer. Semin. Oncol. 1976, 3: 151-159.
81. Shimizu, H.; Ross, R.K.; Bernstein, L.; Yatani, R.; Henderson, B.E.; Mack, TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Brit. J. Cancer. 1991, 63: 963-966.
82. Hirayama, T. Epidemiology of prostate cancer with special reference to the role of diet. Natl. Cancer Inst Monogr. 1979, 53: 149-155.
83. Strom, S.S.; Yamamura, Y.; Duphome, C.M.; Spitz, M.R.; Babaian, R.J.; Pillow, P.C.; Hursting, S.D. Phytoestrogen intake and prostate cancer: a case-control study using a new data-base. Nutr. Cancer 1999, 33: 20-25.
84. Severson, R.K.; Nomura, A.M.; Grove, J.S.; Stemmermann, G.N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989, 49: 1857-1860.
85. Barnes, S.; Peterson, T.G.; Coward, L. Use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J. Cell Biochem. 1995, 22: 181-187.
86. Coward, L.; Barnes, N.C.; Setchell, K.D.R.; Barnes, S. The antitumor isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. J. Agrice. Food Chem. 1993, 41: 1961-1967.
87. Bonina, F.; Puglia, C.; Avogadro, M.; Baranelli, E.; Cravotto, G. The topical protective effect of soybean-germ oil against UVB-induced cutaneous erithema: an in vivo evaluation. Arch. Pharm. Chem. Life Sci. 2005, 338: 598-601.
88. Georgetti, S.R.; Casagrande, R.; Vicentini, T.M.F.; Verri Jr, W.A.; Fonseca, M.J. V. Evaluation of the antioxidant activity of soybean extract by different in vitro methods and investigation of this activity after its incorporation in topical formulations. Eur. J. Pharm. Biopharm. 2006, 64 (1) : 99-106.
89. Zhou, B.F.; Stamler, J.; Dennis, B. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J. Hum. Hypertens. 2003, 17: 623-630.
90. Nagata, C.; Takatsuka, N.; Kurisu, Y.; Shimizu, H. Decreased serum total cholesterol is associated with high intake of soy products in Japanese men and women. J. Nutr. 1998, 128: 209-213.
91. Zhang, X.; Shu, X.O.; Gao, Y.T. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J. Nutr. 2003, 133:2874-2878.
92. Erdman Jr, J.W. Soy protein and cardiovascular disease a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000, 102: 2555-2559.
93. Anderson, J. W.; Johnstone, B.M.; Cook-Newell, M.A. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 1995, 3 33: 276-282.
94. FDA, Ed. FDA approves new health claim for soy protein and coronary heart disease, FDA Talk Paper; United States Food and Drug Administration: Washington, DC, 1999.
95. Crouse Iii, J.R.; Morgan, T.; Terry, J.G.; Ellis, J.; Vitalins, M.; Burke, G.L. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Int. Med. 1999, 159: 2070-2076.
96. Jenkins, D.J.; Kendall, C.W.; Jackson, C J.C. Effects of high- and low-isoflavone soy foods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr. 2002, 76: 365-372.
97. Zhan, S.; Ho, S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 2005, 81: 397-408.
98. Patel, R.P.; Boersma, B.J.; Crawford, J.H. Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic. Biol. Med. 2001, 31: 1570-1581.
99. Boersma, B.J.; Patel, R.P.; Kirk, M. Chlorination and nitration of soy isoflavones. Arch. Biochem. Biophys. 1999, 368: 265-275.
100. Kameoka, S.; Leavitt, P.; Chang, C.; Kuo, SM. Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett. 1999, 146: 161-167.
101. Lai, H.H.; Yen, G.C. Inhibitory effect of isoflavones on peroxynitrite-mediated low-density lipoprotein oxidation. Biosci. Biotech. Biochem. 2002, 66: 22-28.
102. Suzuki, K.; Koike, H.; Matsui, H. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. J. Cancer 2002, 99: 846-852.
103. Guo, Q.; Rimbach, G.; Moini, H.; Weber, S.; Packer, L. ESR and cell culture studies on free radical-scavenging and antioxidant activities of isoflavonoids. Toxicology 2002, 179: 171-180.
104. Hwang, J.; Wang, J.; Morazzoni, P.; Hodis, H.N.; Sevanian, A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radie. Biol. Med. 2003, 34: 1271-1282.
105. Iqbal, M.J.; Yaegashi, S.; Ahsan, R.; Lightfoot, DA.; Banz, W.J. Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate. Physiological Genomics 2002, 11: 219-226.
106. Wiseman, H.; O'reilly, J.D.; Adlercreutz, H.; Mallet, A.I.; Bowey, E.A.; Rowland, I.R.; Sanders, T.A. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 2000, 72: 395-400.
107. Anthony, M.S.; Clarkson, T.B.; Bullock, B.C.; Wagner, J.D. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler. Thromb. Vasc. Biol. 1997, 17: 2524-2531.
108. Anthony, M.S.; Clarkson, T.B.; Williams, J.K. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am. J. Clin. Nutr. 1998, 68: 1390S-1393S.
109. Tikkanen, M.J.; Wahala, K.; Ojala, S.; Vihma, V.; Adlercreutz, H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc. Natl. Acad. Sci. 1998, 95: 3106-3110.
110. Kapiotis, S.; Hermann, M.; Held, I.; Seelos, C.; Ehringer, H.; Gmeiner, B.M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler. Thromb. Vase. Biol. 1997, 17: 2868-2874.
111. Hwang, J.; Sevanian, A.; Hodis, H.N.; Ursini, F. Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid. Free Radie. Biol. Med. 2000, 29: 79-89.
112. Kerry, N.; Abbey, M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis 1998, 140: 341-347.
113. Ruiz-Larrea, M.B.; Mohan, A.R.; Paganga, G.; Miller, N.J.; Bolwell, G.P.; Rice-Evans, C.A. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res. 1997, 26: 63-70.
114. Cuevas, A.M.; Irribarra, V.L.; Castillo, O.A.; Yanez, M.D.; Germain, A.M. Isolated soy protein improves endothelial function in postmenopausal hypercholesterolemic women. Eur. J. Clin. Nutr. 2003, 57: 889-894.
115. Steinberg, F.M.; Guthrie, N.L.; Villablanca, A.C.; Kumar, K.; Murray, M.J. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and anti-oxidant effects in healthy postmenopausal women. Am. J. Clin. Nutr. 2003, 78: 123-130.
116. Wilson, T.; March, H.; Banz, W.J.; Hou, Y.; Adler, S.; Meyers, C.Y.; Winters, T.A.; Mäher, M.A. Antioxidant effects of phyto- and synthetic-estrogens on cupric ion-induced oxidation of human low-density lipoproteins in vitro. Life Sci. 2002, 70: 2287-2297.
117. Jenkins, D.J.; Kendall, C.W.; D'costa, M.A.; Jackson, C.J.; Vidgen, E.; Singer, W. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men. J. Urol. 2003, 169: 507-511.
118. Ashton, E.L.; Dalais, F.S.; Ball, M.J. Effect of meat replacement by tofu on CHD risk factors including copper induced LDL oxidation. J. Am. Coll. Nutr. 2000, 19: 761-767.
119. Meng, Q.H.; Lewis, P.; Wahala, K.; Adlercreutz, H.; Tikkanen, M.J. Incorporation of esterified soybean isoflavones with antioxidant activity into low-density lipoprotein. Biochimica et Biophysica Acta 1999, 1438: 369-376.
120. Lee, J. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006, 79 (16) : 1578-1584.
121. Phillips, DA.; Kapulnik, Y. Plant isoflavonoids, pathogens and symbionts. Trends Microbiol. 1995, 5: 58-64.
122. Harborne, J.B.; Williams, C.A. Advances in flavonoid research since 1992. Phytochemistry 2000, 55: 481-504.
123. Heisig, P. Inhibitors of bacterial topoisomerases: mechanisms of action and resistance and clinical aspects. Planta Med. 2001, 67: 3-12.
124. Bernard, F.X.; Sable, S.; Cameron, B.; Provost, J.; Desnottes, J.F.; Crouzet, J.; Blanche, F. Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob. Agents Chemother. 1997, 41: 992-998.
125. Kim, Y.K.; Jang, Y.Y.; Kim, D.H.; Ko, H.H.; Han, E.S.; Lee, C.S. Differential regulation of protein tyrosine kinase on free radical production, granule enzyme release, and cytokine synthesis by activated murine peritoneal macrophages. Biochem. Pharmacol. 2001, 61: 87-96.
126. Naucler, C.; Grinstein, S.; Sundle, R.; Tapper, H. Signaling to localized degranulation in neutrophils adherent to immune complexes. J. Leukoc. Biol. 2002, 71: 701-710.
127. Verdrengh, M.; Collins, L.V.; Bergin, P.; Tarkowski, A. Phytoestrogen genistein as an anti-staphylococcal agent. Microbes and Infection 2004, 6(1): 86-92.
128. Yellayi, S.; Naaz, A.; Szewczykowski, M.A.; Sato, T.W., J.A.; Chang, J. The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc. Natl. Acad. Sci. 2002, 99: 7616-7621.
129. Yellayi, S.; Zakroczymski, M.A.; Selvaraj, V.; Valli, V.E.; Ghanta, V.; Helferich, W.G. The phytoestrogen genistein suppresses cell-mediated immunity in mice. J. Endocrinol. 2003, 176: 267-274.
130. Barrett, J.R. Soy and children's health: a formula for trouble. Environ. Health Perspect. 2002, 110: A294-A296.
131. Zhao, J.; Sun, S.; Horiguchi, H.; Arao, Y.; Kanamori, N.; Kikuchi, A.; Oguma, E.; Kayama, F. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice. Int. Immunopharmacol. 2005, 5(11): 1601-1610.
132. Salti, G.I.; Grewal, S.; Mehta, R.R.; Das Gupta, T.K.; Boddie Jr., A.W. Constantinou AI. Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur. J. Cancer 2000, 36 (6) : 796-802.
133. Yoon, H.S.; Moon, S.C.; Kim, N.D.; Park, B.S.; Jeong, M.H.; Yoo, Y.H. Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochemie. Biophys. Res. Comm. 2000, 276(1): 151-156.
134. Kumi-Diaka, J.; Butler, A. Caspase-3 protease activation during the process of genistein-induced apoptosis in TM4 testicular cells. Biol. Cell. 2000, 92 (2) : 115-124.
135. Po, L.S.; Wang, T.T.; Chen, Z.Y.; Leung, L.K. Genistein-induced apoptosis in MCF-7 cells involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects. Brit. J. Nutri. 2002, 88 (5) : 463-469.
136. Linford, N.J.; Yang, Y.; Cook, D.G.; Dorsa, D.M. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Therapeutics 2001, 299 (1) : 67-75.
137. Linford, N.J.; Dorsa, D.M. 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 2002, 57(13-14) : 1029-1040.
138. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267 (5203) : 1456-1462.
139. Sastry, P.S.; Rao, K.S. Apoptosis and the nervous system. J. Neurochem. 2000, 74(1): 1-20.
140. Leopold, A.S.; Erwin, M.; Oh, J.; Browning, B. Phytoestrogens: adverse effects on reproduction in California quail. Science 1976, 191 (4222) : 98-100.
141. Dixon, R.A.; Ferreira, D. Genistein. Phytochemistry 2002, 60 (3), 205-211.
142. Choi, E.J.; Lee, B.H. Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sei. 2004, 75 (4) : 499-509.
143. Liener, I.E. Implications of antinutritional components in soybean foods. Crit. Rev. Food. Sei. Nutr. 1994, 34: 31-67.
144. Price, K.R.; Johnson, I.T.; Fenwick, G.R. The chemistry and biological significance of saponins in foods and feedstuff's. Crit. Rev. Food Sei. Nutr. 1987, 26: 27-135.
145. Seeman, P. Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis. Fed. Proc. 1974, 33: 2116-2124.
146. Hu, J.; Lee, S.O.; Hendrich, S.; Murphy, PA. Quantification of the group B soya saponins by high-performance liquid chromatography. J. Agrie. Food Chem. 2002, 50: 2587-2594.
147. Wolf, W.J.; Betty, T. Thin layer and anion exchange chromatography of soybean saponins. J. Am. Oil Chemical Soc. 1970, 47(3) : 86-90.
148. Haralampidis, K.; Trojanowska, M.; Osbourn, A. Biosynthesis of triterpenoid saponins in plants. Ad Biochemical Engin/Biotech. 2002, 75: 31-50.
149. Oboh, G.; Olaleye, M.T.; Akinyosoye, F.A. Haemolytic effect of saponin extracts from soy bean seeds (Glycine max) on some mammalian erythrocytes. Rivista Italiana delle Sostanze Grasse 1999, 76(11): 479-481.
150. Okubo, K.; Kudou, S.; Uchida, T.; Yoshiki, Y.; Yoshikoshi, M.; Tonomura, M. Soybean saponin and isoflavonoids: structure and antiviral activity against human immunodeficiency virus in vitro. In Food Phytochemicals for Cancer Protection I: Fruits and Vegetables, Huang, M.T.; Osawa, T.; Ho, C.T.; Rosen, R.T, Eds.; American Chemical Society: Washington, DC, 1994; 330-339.
151. Sugano, M.; Goto, S.; Yamada, Y.; Yoshida, K.; Hashimoto, Y.; Matsuo, T.; Kimoto, T. Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J. Nutr. 1990, 120: 977-985.
152. Yoshiki, Y.; Kinumi, M.; Kahara, T.; Okubo, K. Chemiluminescence of soybean saponins in the presence of active oxygen species. Plant Sci. 1996, 116: 125-129.
153. Konoshima, T.; Kokumai, M.; Kozuka, M.; Tokuda, H.; Nishino, H.; Iwashima, A. Anti-tumor-promoting activities of afromosin and soya saponin I isolated from Wistaria brachybotrys. J. Nat. Prod. 1992, 55: 1776-1778.
154. Kim, S.E.; Lee, Y.H.; Park, J.H.; Lee, S.K. Ginsenoside-Rs(3), a new diol-type ginseng saponin, selectively elevates protein levels of p53 and p21 (WAF1) leading to induction of apoptosis in SK-HEP-1 cells. Anticancer Res. 1999, 19: 487-491.
155. Rao, A. V.; Sung, M.K. Saponins as anti-carcinogens. J. Nutr. 1995, 125: 717S-724S.
156. Ono, R.; Yamaguchi, M. Anabolic effect of soybean saponin on bone components in the femoral tissues of rats. J. Health Sci. 1999, 45 (5) : 251-255.
157. Gestetner, B.; Birk, Y.; Tencer, Y. Soybean saponins. Fate of ingested soybean saponins and the physiological aspect of their hemolytic activity. J. Agrie. Food Chem. 1968, 16: 1031-1035.
158. Bae, E.A.; Han, M.J.; Choo, M.K.; Park, S.Y.; Kim, D.H. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 2002, 25: 58-63.
159. Akao, T.; Kida, H.; Kanaoka, M.; Hattori, M.; Kobashi, K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenosides Rb1 from Panax ginseng. J. Pharm. Pharmacol. 1998, 50: 1155-1160.
160. Sung, M.K.; Kendall, C.W.C.; Koo, M.M.; Rao, A. V. Effect of soybean saponins and gypsophilla saponin on growth and viability of colon carcinoma cells in culture. Nutr. Cancer 1995, 23: 259-270.
161. Koratkar, R.; Rao, A. V. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer 1997, 27: 206-207.
162. Yoshiki, Y.; Okubo, K. Active oxygen scavenging activity of DDMP (2,3-dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one) saponin in soybean seed. Biosci. Biotech. Biochem. 1995, 59: 1556-1557.
163. Kim, H.Y.; Yu, R.; Kim, J.S.; Kim, Y.K.; Sung, M.K. Antiproliferative crude soy saponin extract modulates the expression of IKBOC, protein kinase C, and cyclooxygenase-2 in human colon cancer cells. Cancer Lett. 2004, 210 (1) : 1-6.
164. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420: 860-867.
165. Chen, Y.C.; Shen, S.C.; Lee, W.R.; Hou, W.C.; Yang, L.L.; Lee, T.J. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J. Cell Biochem. 2001, 82: 537-548.
166. Raso, G.M.; Meli, R.; Di Carlo, G.; Pacilio, M.; Di Carlo, R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage, J774A.1. Life Sci. 2001, 55:921-931.
167. Jeon, Y.H.; Bhoo, S.H.; Hahn, T.R. Molecular characterization of a cDNA encoding chloroplastic fructose-1, 6-bisphosphatase from soybean (Glycine max L.). Mol. Cells 1998, 28: 113-116.
168. Kang, J.-H.; Sung, M.-K.; Kawada, T.; Yoo, H.; Kim, Y.-K.; Kim, J.-S.; Yu, R. Soybean saponins suppress the release of proinflammatory mediators by LPS-stimulated peritoneal macrophages. Cancer Lett. 2005, 230 (2) : 219-227.
169. Award, A.B.; Fink, C.S. Phytosterols as anticancer dietary components: evidence and mechanism of action. J. Nutri. 2000, 130: 2127-2130.
170. Berges, R.R.; Wineler, J.; Trampisch, H.J. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-Sitosterol Study Group. Lancet 1995, 345: 1529-1532.
171. Klippel, K.F.; Hiltl, D.M.; Schipp, B. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study Group. Brit. J. Urol. 1997, 80: 427-432.
172. Kojima, S.; Soga, W.; Hagiwara, H.; Shimonaka, M.; Inada, Y. Visible fibrinolysis by endothelial cells: effect of vitamins and sterols. Biosci. Reports 1986, 5: 1029-1033.
173. Jones, P.J.; Macdougall, D.E.; Ntanios, F.; Vanstone, C.A. Dietary phytosterols as cholesterollowering agents in humans. Cana. J. Physio. Pharmacol. 1997, 75: 217-227.
174. Ostlund Jr., R.E. Phytosterols and cholesterol metabolism. Current Opinion Lipidology 2004, 75:37-41.
175. Satou, H. Physiological effects and safety of plant sterols. Oleoscience 2003, 5: 395-401.
176. Wong, N.C. The beneficial effects of plant sterols on serum cholesterol. Can. J. Cardio. 2001, 17:715-721.
177. Kajimoto, G.; Shibahara, A.; Yamashoji, S. Changes in the contents and compositions of lipids, fatty acids, tocopherols and sterols in soybean seed during maturation. J. Jap. Soc. Nutri. Food Sci. 1982, 35: 345-350.
178. Nagao, A.; Yamazaki, M. Changes in lipid composition of soybean seeds during maturation. J. Jap. Oil Chemist Soc. 1988, 37: 991-999.
179. Yamaya, A.; Endo, Y.; Fujimoto, K.; Kitamura, K. Effects of genetic variability and planting location on the phytosterols content and composition in soybean seeds. Food Chem. 2007, 720(4): 1071-1075.
180. Moghadasian, M.H.; Fröhlich, J.J. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis clinical and experimental evidence. Am. J. Med. 1999, 107: 588-594.
181. FDA. Food and Drug Administration, Food labeling, health claims, plant sterols/stanols esters and coronary heart disease. Fed. Reg. 2000, 65:, 54,686-54,739.
182. Liu, K. Soybeans: Chemistry, technology, and utilization; Chapman & Hall: New York, 1997; 532 pp.
183. Peña-Ramos, E.A.; Xiong, Y.L. Antioxidant activity of soy protein hydrolyzates in a liposomial system. J. Food Sci. 2002, 57(8) : 2952-2956.
184. Grant, G.; Watt, W.B.; Stewart, J.C.; Pusztai, A. Changes in the small intestine and hind-leg muscles of rats induced by dietary soybean (Glicine max) proteins Medical Science Research 1987, 15: 1355-1356.
185. Van Damme Els, J.M.; Peumans, W.J.; Pusztai, A.; Bardocz, S. Handbook of plant lectins: Properties and biomedical applications. Wiley: Chichester, 1997; 224 pp.
186. Stauffer, C.E. Measuring trypsin inhibitor: suggested improvements in the standard method. Cereal Chem. 1990, 67: 296-302.
187. Anderson, R.L.; Wolf, W.J. Compositional changes in trypsin inhibitors, phytic acid, saponins, isoflavones related to soybean processing. J. Nutr. 1995, 725: 581S-588S.
188. Bau, H.M.; Villaume, C.; Giannangeli, F.; Nicolas, J.P.; Mejean, L. Optimisation du chauffage et valeurs nutritionnelle et fonctionnelle des protéines de soja. Cahiers de nutrition et de diététique 2001, 36: 96-102.
189. Calam, J.; Bojarski, J.C.; Springer, C.J. Raw soybean flour increases cholecystokinin release in man. Brit. J. Nutr. 1987, 58: 175-179.
190. Trugo, L.C.; Von Baer, D. Analytical methods for the analysis of antinutritional factors in legume seeds. In Recent advances of research in antinutritional factors in legume seeds and rapeseed; Jansman, A.J.M.; Hill, G.D.; Van der Poel, A.F.B.; Eds.; Wageningen Press:The Netherlands, 1998; 11-28.
191. Baker, E.C.; Mustakas, G.C. Heat inactivation of trypsin inhibitor, lipoxygenase and urease in soybeans: Effect of acid and base additives. J. Am. Oil Chemists' Soc. 1973, 50: 137-141.
192. Melcion, J.P.; Colonna, P. La cuisson extrusion dans le domaine alimentaire: principle, applications, perspectives. Revue de l'alimentation animale 1986, 368: 45-54.
193. Cho, M.J.; Widholm, J.M.; Vodkin, L.O. Cassettes for seed-specific expression tested in transformed embryogénie cultures of soybean. Plant Mol. Biol. Rep. 1995, 13: 255-269.
194. Liener, I.E. Soyin, a toxic protein from the soybean. I: Inhibition of rat growth. J. Nutr. 1953, 49: 527-535.
195. Kelsall, A.; Fitzgerald, A.J.; Howard, C.V.; Evans, R.C.; Singh, R.; Rhodes, J.M.; Goodlad, R.A. Dietary lectins can stimulate pancreatic growth in the rat. Int. J. Exp. Pathol. 2002, 83 (4) : 203-208.
196. Gonzalez, D.-M.E.; Bradford, T.; Hasler, C. The anticarcinogenic potential of soybean lectin and lunasin. Nutr. Rev. 2003, 61 (7) : 239-246.
197. Pusztai, A.; Ewen, S.W.B.; Grant, G.; Peumans, W.J.; Van Damme, E.J.M.; Rubio, L.; Bardocz, S. Relationship between survival and binding of plant lectins during small intestinal passage and their effectiveness as growth factors. Digestion 1990, 46: 308-315.
198. Maenz, D.D.; Irish, G.G.; Classen, H.L. Carbohydrate-binding and agglutinating lectins in raw and processed soybean meals. Anim. Feed Sci.Tech. 1999, 76 (3-4) : 335-343.
199. De Muelenaere, H.J.H. Effect of heat treatment on the nutritive value and hemagglutination activity of legumes. Nature 1964, 201: 1029-1031.
200. Calderon, D.A.M.; Vazquez-Moreno, L.; Robles-Burgueno, M.R. Active soybean lectin in food: Isolation and quantitation. Food Chem. Toxicol. 1991, 39: 321-327.
201. Rizzi, C.; Galeota, L.; Zoccatelli, G.; Vincenzi, S.; Chignola, R.; Angelo, D.B.P. Active soybean lectin in foods: quantitative determination by ELISA using immobilised asialofetuin. Food Res. Int. 2003, 55(8) : 815-821.
202. Munoz, R.; Arias, Y.; Ferreras, J.M.J.; Rojo, M.A.; Girbs, T. Sensitivity of cancer cell lines to the novel non-toxic type 2 ribosome inactivating protein nigrin b. Cancer Lett. 2001, 167 (2) : 163-169.
203. Abdullaev, F.L.; Gonzalez De Mejia, E. Anti-tumor effect of plant lectins. Nat. Toxins 1997, 5: 157-163.
204. Watzl, B.; Neudecker, C.; Hansen, G.M.; Reehkemmer, G.; Pool-Zobel, B.L. Dietary wheat germ agglutinin modulates ovalbumin-induced immune response in Brown Norway rats. Brit. J. Nutr. 2001, 85 (4), 483-490.
205. Ganguly, C.; Das, S. Plant lectins as inhibitors tumor-growth and modulators of immuneresponse. Chemotherapy 1994, 40, 272-278.
206. Sharon, N.; Lis, H. How proteins bind carbohydrates: Lessons from legume lectins. J. Agrie. Food Chem. 2002, 50 (22) : 6586-6591.
207. Gonzalez, D.-M.E.; Prisecaru, I.V. Lectins and bioactive plant proteins: A potential in cancer treatment. Crit. Rev. Food Sci. Nutr. 2005, 45: 425-445.
208. Leterme, P.; Nonmart, T. Importance du tryptophane en alimentation et son dosage dans les aliments. Bull. Rech. Agron. Gembloux 1990, 25: 329-344.
209. Miles, C.W. Effects of vegetable proteins on iron and zinc absorption and availability in humans. J. Am. Chem. Soc. 1989, 66: 924-931.
210. Liu, Y.; Zhang, Q.-Y.; Zhao, Y.-Y.; Wang, B.; Hai, L.-Q.; Ying, Y-P.; Chen, H.-B. Saponins from the roots of Hedysarum polybotrys. Biochemical Systematics Ecol. 2007, 35 (6): 389-391.
211. Kaal, J.; Nieropa, K.G.J.; Verstratena, J.M. Interactions between tannins and goethite- or ferrihydrite-coated quartz sand: Influence of pH and evaporation. Geoderma 2007, 139 (3-4): 379-387.
212. Vasconcelos, I.M.; Maia, A.A.B.; Siebra, E.A.; José T. A. Oliveira, J.T.A.; Carvalho, A.F.F.U.; Melo, V.M.M.; Carlini, C.R.; Castelar, L.I.M. Nutritional study of two Brazilian soybean (Glycine max) cultivars differing in the contents of antinutritional and toxic proteins. J. Nutr. Biochem. 2001, 12 (1): 55-62.